CFI-402257 in Combination With Paclitaxel in Patients With Advanced/Metastatic HER2-Negative Breast Cancer

NCT03568422 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
37
Enrollment
NETWORK
Sponsor class

Conditions

Interventions

Sponsor

Canadian Cancer Trials Group

Collaborators